RD
RadNet
RDNT · NASDAQ
$71.97 -0.87% (-$0.63)
1M -6.87%
Market Cap $5.66B
P/E Ratio -
Div. Yield -
ROE 1.95%
Bulios Fair Price
$48.14
33.1% downside
Current Price
$71.97
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RDNT is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
34 /100
Fair P/S 2.49x
P/B 5.16x
EV/EBITDA 21.10x
Growth
82 /100
Growing Book val. growth 48.47%
Rev. growth 12.57%
FCF growth N/A
Profitability
6 /100
Weak FCF margin 2.58%
Op. margin 4.00%
Gross margin 9.70%
Quality
8 /100
Poor Asset turnover 0.54x
ROA 0.50%
ROIC 1.38%
Debt
28 /100
High Net debt/EBITDA 4.32x
Int. coverage 1.49x
Debt/Equity 1.99x
Stability
41 /100
Moderate Profitable years 0
EPS volatility 417.65%
Beta 1.40x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RDNT
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Howard G. Berger
Employees
9,060
Headquarters
Los Angeles
Upcoming events
09 NOV
Earnings
Upcoming earnings report